Skip to Main Content (Press Enter)

Logo UNIMORE
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills

UNI-FIND
Logo UNIMORE

|

UNI-FIND

unimore.it
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills
  1. Research Outputs

Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study

Academic Article
Publication Date:
2025
Short description:
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study / Fianchi, Luana; Piciocchi, Alfonso; Guolo, Fabio; Marchesi, Francesco; Marsili, Giovanni; Cattaneo, Chiara; Gottardi, Michele; Restuccia, Francesco; Candoni, Anna; Ortu La Barbera, Elettra; Fazzi, Rita; Pasciolla, Crescenza; Finizio, Olimpia; Fracchiolla, Nicola; Delia, Mario; Lessi, Federica; Dargenio, Michela; Bonuomo, Valentina; Del Principe, Maria Ilaria; Zappasodi, Patrizia; Picardi, Marco; Basilico, Claudia; Piedimonte, Monica; Minetto, Paola; Chiusolo, Patrizia; Prezioso, Lucia; Buquicchio, Caterina; Melillo, Lorella; Zama, Daniele; Farina, Francesca; Mancini, Valentina; Rondoni, Michela; Busca, Alessandro; Pagano, Livio. - In: ANNALS OF HEMATOLOGY. - ISSN 0939-5555. - 104:5(2025), pp. 2731-2736. [10.1007/s00277-025-06381-3]
abstract:
: A real-life study on CPX-351 and the standard arm ('7 + 3') of the CPX-351 registrative trial in adults with secondary Acute Myeloid Leukemia were compared by an unanchored Matching-adjusted indirect comparison (MAIC), in order to evaluate the efficacy and toxicity of CPX-351. Results of this study are important to confirm the role of CPX-351 in significantly improving survival and remission rates compared with '7 + 3' with a good safety profile in AML patients with high-risk features, a target group traditionally with a very poor prognosis. Moreover, this pilot analysis underlines the potentiality of the statistical method to compare studies with strong differences.
Iris type:
Articolo su rivista
Keywords:
CPX- 351; Matching-adjusted indirect comparison; Secondary acute myeloid leukemia
List of contributors:
Fianchi, Luana; Piciocchi, Alfonso; Guolo, Fabio; Marchesi, Francesco; Marsili, Giovanni; Cattaneo, Chiara; Gottardi, Michele; Restuccia, Francesco; Candoni, Anna; Ortu La Barbera, Elettra; Fazzi, Rita; Pasciolla, Crescenza; Finizio, Olimpia; Fracchiolla, Nicola; Delia, Mario; Lessi, Federica; Dargenio, Michela; Bonuomo, Valentina; Del Principe, Maria Ilaria; Zappasodi, Patrizia; Picardi, Marco; Basilico, Claudia; Piedimonte, Monica; Minetto, Paola; Chiusolo, Patrizia; Prezioso, Lucia; Buquicchio, Caterina; Melillo, Lorella; Zama, Daniele; Farina, Francesca; Mancini, Valentina; Rondoni, Michela; Busca, Alessandro; Pagano, Livio
Authors of the University:
CANDONI ANNA
Handle:
https://iris.unimore.it/handle/11380/1378589
Full Text:
https://iris.unimore.it//retrieve/handle/11380/1378589/897042/unpaywall-bitstream-1785218944.pdf
Published in:
ANNALS OF HEMATOLOGY
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.4.0.0